We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRV icon
326
Travelers Companies
TRV
$81.1B
$5.34M 0.03%
23,199
+770
+3% +$165K
PCRX icon
327
Pacira BioSciences
PCRX
$1.04B
$5.32M 0.03%
181,901
-10,000
-5% -$307K
BX icon
328
Blackstone
BX
$104B
$5.26M 0.03%
40,023
+1,613
+4% +$201K
KMI icon
329
Kinder Morgan
KMI
$70.9B
$5.22M 0.03%
284,725
+25,808
+10% +$451K
GWW icon
330
W.W. Grainger
GWW
$64.2B
$5.2M 0.03%
5,107
+51
+1% +$47.5K
WFG icon
331
West Fraser Timber
WFG
$5.21B
$5.18M 0.03%
59,885
-15,650
-21% -$1.28M
SKT icon
332
Tanger
SKT
$4.78B
$5.15M 0.03%
+174,277
New +$4.88M
POWI icon
333
Power Integrations
POWI
$3.15B
$5.14M 0.03%
71,826
TTWO icon
334
Take-Two Interactive
TTWO
$46.1B
$5.12M 0.03%
34,463
-32,501
-49% -$5.05M
PRU icon
335
Prudential Financial
PRU
$42.6B
$5.03M 0.03%
42,873
+3,158
+8% +$340K
CMG icon
336
Chipotle Mexican Grill
CMG
$43.9B
$5M 0.03%
86,000
+7,150
+9% +$366K
IRON icon
337
Disc Medicine
IRON
$2.81B
$4.98M 0.03%
80,000
STN icon
338
Stantec
STN
$8.17B
$4.94M 0.03%
59,457
+22,478
+61% +$1.85M
VRDN icon
339
Viridian Therapeutics
VRDN
$2.2B
$4.9M 0.03%
+280,000
New +$5.43M
GMED icon
340
Globus Medical
GMED
$11.1B
$4.87M 0.03%
90,792
+37,735
+71% +$2.03M
WMB icon
341
Williams Companies
WMB
$85.8B
$4.87M 0.03%
124,884
+4,529
+4% +$161K
PTCT icon
342
PTC Therapeutics
PTCT
$6.18B
$4.86M 0.03%
167,048
-124,604
-43% -$3.49M
PCAR icon
343
PACCAR
PCAR
$70.5B
$4.85M 0.03%
39,174
+1,167
+3% +$125K
PSX icon
344
Phillips 66
PSX
$82.9B
$4.83M 0.03%
29,577
+2,518
+9% +$363K
MDGL icon
345
Madrigal Pharmaceuticals
MDGL
$12.6B
$4.81M 0.03%
18,000
-9,000
-33% -$2.12M
DAWN
346
DELISTED
Day One Biopharmaceuticals
DAWN
$4.79M 0.03%
290,014
SDGR icon
347
Schrodinger
SDGR
$1.13B
$4.78M 0.03%
177,000
+35,000
+25% +$979K
EW icon
348
Edwards Lifesciences
EW
$49.4B
$4.75M 0.03%
49,663
+1,742
+4% +$146K
VERA icon
349
Vera Therapeutics
VERA
$2.33B
$4.66M 0.03%
+108,000
New +$3.85M
URI icon
350
United Rentals
URI
$65.7B
$4.64M 0.03%
6,428
-34,883
-84% -$22.4M

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.